Kairos Pharma, LTD. reports its Q3 results, revealing ongoing revenue challenges in the competitive pharmaceutical preparations sector.
| Name | Kairos Pharma, LTD. |
|---|---|
| CIK | 0001962011 |
| Tickers | KAPA |
| Exchanges | NYSE |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 462993314 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 818-404-5541 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Kairos Pharma, LTD. reports its Q3 results, revealing ongoing revenue challenges in the competitive pharmaceutical preparations sector.
Kairos Pharma, LTD. has been awarded the 2026 Biotech Breakthrough Award for its cancer treatment ENV-105, showcasing innovation in the pharmaceutical industry.
Kairos Pharma has amended its equity line of credit with Helena Global, extending the agreement and altering pricing terms to enhance funding flexibility.
Kairos Pharma announces positive interim results from its Phase 2 trial of ENV-105 for metastatic prostate cancer, marking a significant advancement in treatment options.
127 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | PRE 14A | PRE 14A | 0001493152-26-053578 | 001-42275 | 261580325 | 34 | 1173216 | |||
| 2026-11-13 | 10-Q | 10-Q | 0001493152-26-051822 | 001-42275 | 261553898 | 34 | 4609358 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-050094 | 001-42275 | 261525149 | 34 | 248167 | 1 | 1 |
| 2026-11-03 | 8-K | 8-K | 1.01,8.01,9.01 | 0001493152-26-049744 | 001-42275 | 261515477 | 34 | 10063881 | 1 | 1 |
| 2026-10-06 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-045844 | 001-42275 | 261442303 | 34 | 220383 | 1 | 1 |
| 2026-09-14 | 8-K | 8-K | 7.01,9.01 | 0001493152-26-042569 | 001-42275 | 261377288 | 34 | 4356963 | 1 | 1 |
| 2026-08-21 | 8-K | 8-K | 3.03,5.03,7.01,9.01 | 0001493152-26-039695 | 001-42275 | 261305113 | 34 | 264644 | 1 | 1 |
| 2026-08-12 | 10-Q | 10-Q | 0001493152-26-037355 | 001-42275 | 261267575 | 34 | 4915969 | 1 | 1 | |
| 2026-07-22 | 8-K | 8-K | 1.01,8.01,9.01 | 0001493152-26-034185 | 001-42275 | 261191735 | 34 | 509225 | 1 | 1 |
| 2026-07-15 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-033289 | 001-42275 | 261176028 | 34 | 250498 | 1 | 1 |
| 2026-06-30 | 8-K | 8-K | 5.07 | 0001493152-26-031328 | 001-42275 | 261141633 | 34 | 234910 | 1 | 1 |
| 2026-06-04 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-027200 | 001-42275 | 261063245 | 34 | 242274 | 1 | 1 |
| 2026-05-26 | DEFA14A | DEFA14A | 0001493152-26-025287 | 001-42275 | 261021203 | 34 | 16762 | |||
| 2026-05-22 | ARS | ARS | 0001493152-26-025021 | 001-42275 | 261013886 | 34 | 2956866 | |||
| 2026-05-22 | DEF 14A | DEF 14A | 0001493152-26-025020 | 001-42275 | 261013841 | 34 | 2711566 | 1 | 1 | |
| 2026-05-18 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-024082 | 001-42275 | 26990886 | 34 | 31925740 | 1 | 1 |
| 2026-05-13 | 10-Q | 10-Q | 0001493152-26-022796 | 001-42275 | 26974670 | 34 | 16758567 | 1 | 1 | |
| 2026-05-11 | PRE 14A | PRE 14A | 0001493152-26-022194 | 001-42275 | 26962318 | 34 | 2496551 | 1 | 1 | |
| 2026-04-01 | 424B3 | 424B3 | 0001493152-26-014692 | 333-284569 | 26829123 | 33 | 5002147 | |||
| 2026-04-01 | 424B3 | 424B3 | 0001493152-26-014691 | 333-286662 | 26829122 | 33 | 5003047 | |||
| 2026-03-31 | 10-K | 10-K | 0001493152-26-014159 | 001-42275 | 26821834 | 34 | 11098857 | 1 | 1 | |
| 2026-03-02 | 8-K | 8-K | 1.01,8.01,9.01 | 0001493152-26-008435 | 001-42275 | 26703329 | 34 | 289592 | 1 | 1 |
| 2026-02-26 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-008116 | 001-42275 | 26681623 | 34 | 230534 | 1 | 1 |
| 2026-01-23 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000284 | 333-292686 | 26558316 | 33 | 1715 | ||
| 2026-01-21 | CORRESP | filename1.htm | 0001493152-26-002996 | 12344 | ||||||
| 2026-01-15 | UPLOAD | filename1.pdf | 0000000000-26-000555 | 333-292686 | 40033 | |||||
| 2026-01-13 | S-3 | S-3 | 0001493152-26-001909 | 333-292686 | 26527994 | 33 | 1097355 | 1 | 1 | |
| 2025-12-30 | 4 | 4 | 0001493152-25-029601 | 5052 | ||||||
| 2025-12-23 | 4 | 4 | 0001493152-25-028895 | 7080 | ||||||
| 2025-11-26 | 4 | 4 | 0001493152-25-025224 | 5068 | ||||||
| 2025-11-26 | 4 | 4 | 0001493152-25-025205 | 7094 | ||||||
| 2025-11-26 | 4 | 4 | 0001493152-25-025203 | 4941 | ||||||
| 2025-11-26 | 4 | 4 | 0001493152-25-025198 | 5072 | ||||||
| 2025-11-26 | 4 | 4 | 0001493152-25-025197 | 5734 | ||||||
| 2025-11-14 | 10-Q | 10-Q | 0001493152-25-023276 | 001-42275 | 251484135 | 34 | 16912721 | 1 | 1 | |
| 2025-10-15 | 8-K | 8-K | 5.02,9.01 | 0001493152-25-018145 | 001-42275 | 251394941 | 34 | 256438 | 1 | 1 |
| 2025-10-07 | 8-K | 8-K | 1.01,8.01,9.01 | 0001493152-25-017208 | 001-42275 | 251378269 | 34 | 275204 | 1 | 1 |
| 2025-09-18 | 8-K | 8-K | 8.01,9.01 | 0001493152-25-013975 | 001-42275 | 251321799 | 34 | 6177284 | 1 | 1 |
| 2025-09-11 | 8-K | 8-K | 8.01,9.01 | 0001493152-25-013040 | 001-42275 | 251307244 | 34 | 233374 | 1 | 1 |
| 2025-09-03 | 8-K | 8-K | 8.01,9.01 | 0001641172-25-026316 | 001-42275 | 251287798 | 34 | 235827 | 1 | 1 |
| 2025-08-19 | 424B3 | 424B3 | 0001641172-25-024858 | 333-284569 | 251232899 | 33 | 2699771 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003587 | 005-95030 | 251222147 | 34 | 10531 | |||
| 2025-08-12 | 10-Q | 10-Q | 0001641172-25-023167 | 001-42275 | 251206296 | 34 | 4640368 | 1 | 1 | |
| 2025-07-28 | 10-K/A | 10-K/A | 0001641172-25-021134 | 001-42275 | 251154559 | 34 | 706639 | 1 | 1 | |
| 2025-07-15 | 8-K | 8-K | 8.01,9.01 | 0001641172-25-019645 | 001-42275 | 251123296 | 34 | 229154 | 1 | 1 |
| 2025-06-12 | 8-K | 8-K | 1.01,5.07,9.01 | 0001641172-25-014905 | 001-42275 | 251043771 | 34 | 294504 | 1 | 1 |
| 2025-06-03 | 8-K | 8-K | 8.01,9.01 | 0001641172-25-013368 | 001-42275 | 251017219 | 34 | 232506 | 1 | 1 |
| 2025-05-16 | DEFR14A | DEFR14A | 0001641172-25-011229 | 001-42275 | 25958709 | 34 | 2416680 | 1 | 1 | |
| 2025-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002232 | 005-95030 | 25951877 | 34 | 10356 | |||
| 2025-05-14 | 10-Q | 10-Q | 0001641172-25-010089 | 001-42275 | 25942550 | 34 | 4269456 | 1 | 1 | |
| 2025-05-06 | PRER14A | PRER14A | 0001641172-25-008787 | 001-42275 | 25916248 | 34 | 2416901 | 1 | 1 | |
| 2025-05-01 | DEF 14A | DEF 14A | 0001641172-25-007922 | 001-42275 | 25897759 | 34 | 4064389 | 1 | 1 | |
| 2025-04-30 | 3 | xslF345X02/ownership.xml | 0001641172-25-007758 | 4075 | ||||||
| 2025-04-29 | 10-K/A | AMENDMENT TO THE FORM 10-K | 0001641172-25-006509 | 001-42275 | 25881899 | 34 | 488087 | 1 | 1 | |
| 2025-04-28 | 8-K | 8-K | 4.01,9.01 | 0001641172-25-006504 | 001-42275 | 25881700 | 34 | 217860 | 1 | 1 |
| 2025-04-25 | 424B3 | form424b3.htm | 0001641172-25-006278 | 333-286662 | 25875195 | 33 | 901682 | |||
| 2025-04-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001242 | 333-286662 | 25869719 | 33 | 1715 | ||
| 2025-04-24 | 8-K | form8-k.htm | 8.01,9.01 | 0001641172-25-005946 | 001-42275 | 25863709 | 34 | 237692 | 1 | 1 |
| 2025-04-22 | CORRESP | filename1.htm | 0001641172-25-005650 | 14178 | ||||||
| 2025-04-22 | S-1 | forms-1.htm | 0001641172-25-005602 | 333-286662 | 25854671 | 33 | 1095862 | |||
| 2025-04-15 | 10-K | form10-k.htm | 0001641172-25-004920 | 001-42275 | 25840720 | 34 | 7707396 | 1 | 1 | |
| 2025-04-07 | 4 | xslF345X05/ownership.xml | 0001641172-25-002927 | 5089 | ||||||
| 2025-03-28 | NT 10-K | formnt10-k.htm | 0001641172-25-001186 | 001-42275 | 25786073 | 34 | 32538 | |||
| 2025-03-20 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-010977 | 001-42275 | 25754500 | 34 | 256322 | 1 | 1 |
| 2025-02-26 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-008268 | 001-42275 | 25666125 | 34 | 243048 | 1 | 1 |
| 2025-02-24 | 4 | xslF345X05/ownership.xml | 0001493152-25-008106 | 5140 | ||||||
| 2025-02-24 | 4 | xslF345X05/ownership.xml | 0001493152-25-008105 | 5089 | ||||||
| 2025-02-10 | DEF 14C | formdef14c.htm | 0001493152-25-005657 | 001-42275 | 25606310 | 34 | 111994 | |||
| 2025-02-06 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-005100 | 001-42275 | 25595632 | 34 | 240727 | 1 | 1 |
| 2025-02-05 | 424B3 | form424b3.htm | 0001493152-25-004882 | 333-284569 | 25590720 | 33 | 10072823 | 1 | 1 | |
| 2025-02-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000308 | 333-284569 | 25590619 | 33 | 1722 | ||
| 2025-01-31 | CORRESP | filename1.htm | 0001493152-25-004493 | 13486 | ||||||
| 2025-01-31 | UPLOAD | filename1.pdf | 0000000000-25-001047 | 333-284569 | 39996 | |||||
| 2025-01-29 | PRE 14C | formpre14c.htm | 0001493152-25-004079 | 001-42275 | 25566688 | 34 | 111665 | |||
| 2025-01-29 | S-1 | forms-1.htm | 0001493152-25-004041 | 333-284569 | 25566614 | 33 | 10369935 | 1 | 1 | |
| 2025-01-28 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-25-003984 | 021-536526 | 25564233 | 33 | 12227 | ||
| 2025-01-17 | 8-K | form8-k.htm | 1.01,3.02,9.01 | 0001493152-25-002832 | 001-42275 | 25539618 | 34 | 990534 | 1 | 1 |
| 2025-01-14 | 8-K | form8-k.htm | 1.01,3.02,9.01 | 0001493152-25-002048 | 001-42275 | 25527959 | 34 | 1132512 | 1 | 1 |
| 2025-01-06 | UPLOAD | filename1.pdf | 0000000000-25-000132 | 377-07661 | 40277 | |||||
| 2025-01-03 | DRS | filename1.htm | 0001493152-25-000210 | 377-07661 | 25505209 | 33 | 3162048 | |||
| 2024-12-13 | 8-K | form8-k.htm | 5.02,9.01 | 0001493152-24-049994 | 001-42275 | 241548429 | 34 | 271521 | 1 | 1 |
| 2024-11-25 | 4 | xslF345X05/ownership.xml | 0001493152-24-047695 | 4523 | ||||||
| 2024-11-25 | 4 | xslF345X05/ownership.xml | 0001493152-24-047526 | 4527 | ||||||
| 2024-11-21 | 4 | xslF345X05/ownership.xml | 0001493152-24-047261 | 4476 | ||||||
| 2024-11-19 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-24-046707 | 001-42275 | 241473464 | 34 | 278231 | 1 | 1 |
| 2024-11-14 | 10-Q | form10-q.htm | 0001493152-24-045671 | 001-42275 | 241460326 | 34 | 5756385 | 1 | 1 | |
| 2024-10-10 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-24-040780 | 001-42275 | 241365953 | 34 | 32892204 | 1 | 1 |
| 2024-10-04 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-24-039586 | 001-42275 | 241355767 | 34 | 270605 | 1 | 1 |
| 2024-09-27 | S-8 | forms-8.htm | 0001493152-24-038599 | 333-282391 | 241335987 | 33 | 155146 | |||
| 2024-09-27 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-24-038590 | 001-42275 | 241335924 | 34 | 750667 | 1 | 1 |
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038032 | 3533 | ||||||
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038031 | 3523 | ||||||
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038030 | 3575 | ||||||
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038029 | 3575 | ||||||
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038028 | 3578 | ||||||
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038027 | 3526 | ||||||
| 2024-09-24 | 3 | xslF345X02/ownership.xml | 0001493152-24-038026 | 3539 | ||||||
| 2024-09-24 | 8-K | form8-k.htm | 1.01,8.01,9.01 | 0001493152-24-037958 | 001-42275 | 241320430 | 34 | 373091 | 1 | 1 |
| 2024-09-17 | 8-K | form8-k.htm | 1.01,7.01,9.01 | 0001493152-24-036855 | 001-42275 | 241304613 | 34 | 911419 | 1 | 1 |
| 2024-09-17 | 424B4 | form424b4.htm | 0001493152-24-036474 | 333-274805 | 241302547 | 33 | 3200467 | |||
| 2024-09-16 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2024-09-16 10:30:00 | 9999999995-24-002852 | 333-274805 | 241302417 | 33 | 1723 | ||
| 2024-09-13 | CORRESP | filename1.htm | 0001493152-24-036216 | 12301 | ||||||
| 2024-09-13 | CORRESP | filename1.htm | 0001493152-24-036173 | 17086 | ||||||
| 2024-09-13 | CORRESP | filename1.htm | 0001493152-24-036171 | 12347 | ||||||
| 2024-09-12 | CERT | NYSE AMERICAN CERTIFICATION | 0001143313-24-000088 | 001-42275 | 241294553 | 34 | 390663 | |||
| 2024-09-12 | 8-A12B | form8a-12b.htm | 0001493152-24-035986 | 001-42275 | 241294412 | 34 | 24308 | |||
| 2024-09-09 | CORRESP | filename1.htm | 0001493152-24-035460 | 11581 | ||||||
| 2024-09-09 | CORRESP | filename1.htm | 0001493152-24-035422 | 17223 | ||||||
| 2024-08-16 | S-1/A | forms-1a.htm | 0001493152-24-032896 | 333-274805 | 241217722 | 33 | 3600165 | |||
| 2024-06-04 | S-1/A | forms-1a.htm | 0001493152-24-022450 | 333-274805 | 241015816 | 33 | 3316448 | |||
| 2024-06-03 | CORRESP | filename1.htm | 0001493152-24-022452 | 16633 | ||||||
| 2024-05-24 | S-1/A | forms-1a.htm | 0001493152-24-021364 | 333-274805 | 24984753 | 33 | 3314972 | |||
| 2024-05-20 | S-1/A | forms-1a.htm | 0001493152-24-020539 | 333-274805 | 24962396 | 33 | 3312211 | |||
| 2024-05-13 | S-1/A | forms-1a.htm | 0001493152-24-018727 | 333-274805 | 24936605 | 33 | 3313022 | |||
| 2024-05-01 | S-1/A | forms-1a.htm | 0001493152-24-017318 | 333-274805 | 24899577 | 33 | 3732941 | |||
| 2024-02-14 | S-1/A | forms-1a.htm | 0001493152-24-006764 | 333-274805 | 24640782 | 33 | 3543187 | |||
| 2023-12-07 | S-1/A | forms-1a.htm | 0001493152-23-043914 | 333-274805 | 231470655 | 33 | 3543492 | |||
| 2023-09-29 | S-1 | forms-1.htm | 0001493152-23-034915 | 333-274805 | 231296786 | 33 | 9579805 | |||
| 2023-09-18 | DRS/A | filename1.htm | 0001493152-23-032840 | 377-06654 | 231259961 | 33 | 3486057 | |||
| 2023-09-15 | DRSLTR | filename1.htm | 0001493152-23-032842 | 33799 | ||||||
| 2023-07-06 | UPLOAD | filename1.pdf | 0000000000-23-007216 | 377-06654 | 53267 | |||||
| 2023-06-28 | DRSLTR | filename1.htm | 0001493152-23-022727 | 87165 | ||||||
| 2023-06-28 | DRS/A | filename1.htm | 0001493152-23-022725 | 377-06654 | 231050474 | 33 | 58404988 | |||
| 2023-06-28 | DRS/A | filename1.htm | 0001493152-23-022724 | 377-06654 | 231050424 | 33 | 67312370 | |||
| 2023-04-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-23-013724 | 021-480119 | 23851219 | 33 | 10980 | ||
| 2023-04-25 | UPLOAD | filename1.pdf | 0000000000-23-004179 | 377-06654 | 72584 | |||||
| 2023-03-29 | DRS | filename1.htm | 0001493152-23-009350 | 377-06654 | 23771465 | 33 | 2645932 |
One latest value per concept from companyfacts (119 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 4.69M | 2026-11-13 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| dei | EntityListingParValuePerShare | Entity Listing, Par Value Per Share | USD/shares | 0.001 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 |
| dei | EntityPublicFloat | Entity Public Float | USD | 6.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 495,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | AccountsPayableTradeCurrentAndNoncurrent | Accounts Payable, Trade | USD | 15.00M | 2026-03-02 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | AdditionalCollateralAggregateFairValue | Additional Collateral, Aggregate Fair Value | USD | 500,000 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 23.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 5,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 29,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 154,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | AmortizationOfDeferredCharges | Amortization of Deferred Charges | USD | 87,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 62,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 717,563 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | Assets | Assets | USD | 4.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 3.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | Cash | Cash | USD | 1.27M | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 3.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 3.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -1.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 4.29 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 100.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 3.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 3.73M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 4,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | ConvertibleLongTermNotesPayable | Convertible Notes Payable, Noncurrent | USD | 638,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 250,000 | 2022-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | CustomerAdvancesAndDeposits | Customer Advances and Deposits | USD | 3.12M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | DebtInstrumentFaceAmount | Debt Instrument, Face Amount | USD | 142,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 | |
| us-gaap | DebtInstrumentIncreaseAccruedInterest | Debt Instrument, Increase, Accrued Interest | USD | 3,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 |
| us-gaap | DebtInstrumentPeriodicPayment | Debt Instrument, Periodic Payment | USD | 0 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 105,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 105,000 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 239,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 1.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 239,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 482,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 2.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpense | Deferred Tax Assets, Tax Deferred Expense | USD | 3.25M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 386,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 3.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.6 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.28 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.039 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.005 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.07 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 29,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 191,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037355 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 2.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-13 | 0001493152-26-022796 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 1.52M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 102,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -1.14M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | -13,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | -381,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 296,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -26,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 62,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 35,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 3,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | InterestReceivable | Interest Receivable | USD | 0 | 2023-12-31 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 | |
| us-gaap | InvestmentIncomeNet | Investment Income, Net | USD | 90,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | Liabilities | Liabilities | USD | 992,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 4.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 495,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | MoneyMarketFundsAtCarryingValue | Money Market Funds, at Carrying Value | USD | 2.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 1.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -3.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -5.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 90,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Integer | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 5.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -5.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 9.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 727,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 193,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 670,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 2.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | PaymentsForAdvanceToAffiliate | Payments for Advance to Affiliate | USD | 900,000 | 2024-10-01 | 2024-10-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | PaymentsOfFinancingCosts | Payments of Financing Costs | USD | 209,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 25,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 1.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 3.06M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001493152-25-023276 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 3.06M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 3.60M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 142,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 142,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 10,000 | 2022-01-01 | 2022-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 2.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -19.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | ServicingAssetAtAmortizedValue | Servicing Asset at Amortized Cost | USD | 18,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-12 | 0001493152-26-037355 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 278,188 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 93,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 80,000 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001493152-24-045671 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 3.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 | |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfUnits | Stock Issued During Period, Shares, Conversion of Units | shares | 514,940 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 551,100 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-14 | 0001641172-25-010089 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 884,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 1.79M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 7,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 75.00M | 2026-01-01 | 2026-01-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 1.88M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-31 | 0001493152-26-014159 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardGross | Stock Issued During Period, Value, Restricted Stock Award, Gross | USD | 777,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 218,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001641172-25-004920 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 3.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 3.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001493152-26-051822 |